Spengler, G.; Gajdács, M.; Marć, M.A.; Domínguez-Álvarez, E.; Sanmartín, C.
Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance. Molecules 2019, 24, 336.
https://doi.org/10.3390/molecules24020336
AMA Style
Spengler G, Gajdács M, Marć MA, Domínguez-Álvarez E, Sanmartín C.
Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance. Molecules. 2019; 24(2):336.
https://doi.org/10.3390/molecules24020336
Chicago/Turabian Style
Spengler, Gabriella, Márió Gajdács, Małgorzata Anna Marć, Enrique Domínguez-Álvarez, and Carmen Sanmartín.
2019. "Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance" Molecules 24, no. 2: 336.
https://doi.org/10.3390/molecules24020336
APA Style
Spengler, G., Gajdács, M., Marć, M. A., Domínguez-Álvarez, E., & Sanmartín, C.
(2019). Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance. Molecules, 24(2), 336.
https://doi.org/10.3390/molecules24020336